0010B |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Blood |
0010SP |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Serum/Plasma |
0010U |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Urine |
0014B |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Blood |
0014SP |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Serum/Plasma |
0014U |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Urine |
0015B |
2-methyl AP-237 & AP-238, Blood |
0015SP |
2-methyl AP-237 & AP-238, Serum/Plasma |
0015U |
2-methyl AP-237 & AP-238, Urine |
0205B |
Acetyl Fentanyl, Blood |
0205SP |
Acetyl Fentanyl, Serum/Plasma |
0205U |
Acetyl Fentanyl and Metabolite, Urine |
0307B |
Amiodarone and Metabolite, Blood |
0307SP |
Amiodarone and Metabolite, Serum/Plasma |
0570B |
Designer Benzodiazepines, Blood |
0570SP |
Designer Benzodiazepines, Serum/Plasma |
0570U |
Designer Benzodiazepines (Qualitative), Urine |
0641B |
Sotalol, Blood |
0641SP |
Sotalol, Serum/Plasma |
0771B |
Brorphine, Blood |
0771SP |
Brorphine, Serum/Plasma |
0771U |
Brorphine, Urine |
1021B |
Substituted Cathinone Panel, Blood |
1021SP |
Substituted Cathinone Panel, Serum/Plasma |
1021U |
Substituted Cathinone Panel, Urine |
1022B |
Eutylone, Blood |
1022SP |
Eutylone, Serum/Plasma |
1022U |
Eutylone (Qualitative), Urine |
1033ST |
Cathartic Laxatives Profile, Stool |
1480B |
Designer Opioids, Blood |
1480SP |
Designer Opioids, Serum/Plasma |
1480U |
Designer Opioids (Qualitative), Urine |
1483B |
Desalkylgidazepam, Blood |
1483SP |
Desalkylgidazepam, Serum/Plasma |
1483U |
Desalkylgidazepam (Qualitative), Urine |
1613SP |
Digitoxin, Serum/Plasma |
1615B |
Digoxin, Blood |
1615FL |
Digoxin, Fluid |
1615SP |
Digoxin, Serum/Plasma |
1615TI |
Digoxin, Tissue |
1828B |
Dronedarone, Blood |
1828SP |
Dronedarone, Serum/Plasma |
2088B |
Flecainide, Blood |
2088SP |
Flecainide, Serum/Plasma |
2088U |
Flecainide, Urine |
2499U |
Laxatives Panel (Qualitative), Urine |
2626B |
Bath Salts Panel (Qualitative), Blood |
2626SP |
Bath Salts Panel (Qualitative), Serum/Plasma |
2626U |
Bath Salts Panel (Qualitative), Urine |
3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3064B |
Mitragynine, Blood |
3064SP |
Mitragynine, Serum/Plasma |
3078U |
Mitragynine (Qualitative), Urine |
3092SP |
Moricizine, Serum/Plasma |
3168B |
Nitazenes Panel, Blood |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |
4047B |
Pyrrolidinophenone Panel, Blood |
4047SP |
Pyrrolidinophenone Panel, Serum/Plasma |
4071B |
Quinidine, Blood |
4071SP |
Quinidine, Serum/Plasma |
4075B |
Quinine/Quinidine Differentiation, Blood |
4075SP |
Quinine/Quinidine Differentiation, Serum/Plasma |
4282SP |
Synthetic Cannabinoids (Qualitative), Serum/Plasma |
4283U |
Synthetic Cannabinoid Metabolites-Expanded (Qualitative), Urine |
8054B |
NMS TotalTox™ Panel, Blood (Forensic) Overview: Forensic Analysis; Exclusion Screen; This test is New York State approved. |
8756B |
Novel Psychoactive Substances (NPS) Screen 1, Blood |
8756SP |
Novel Psychoactive Substances (NPS) Screen 1, Serum/Plasma |
8756U |
Novel Psychoactive Substances (NPS) Screen 1, Urine |
9105B |
Acetyl Fentanyl Screen, Blood |
9105SP |
Acetyl Fentanyl Screen, Serum/Plasma |
9105U |
Acetyl Fentanyl Screen, Urine |
9159B |
Disopyramide Screen, Blood |
9159SP |
Disopyramide Screen, Serum/Plasma |
9211B |
Mexiletine Screen, Blood |
9211SP |
Mexiletine Screen, Serum/Plasma |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |